1-20 of 27
Authors: D Monfort
Sort by
Journal Article
P0124 Therapeutic Potential of Adipose-Derived Extracellular Vesicles for Inflammation Modulation and Mucosal Healing in Crohn’s Disease Free
L Clua and others
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i508, https://doi.org/10.1093/ecco-jcc/jjae190.0298
Published: 22 January 2025
Journal Article
P0133 Activation of Adipose Tissue Browning as a Potential Therapeutic Approach to Reduce Inflammation in Crohn’s Disease Free
A Boronat-Toscano and others
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i520, https://doi.org/10.1093/ecco-jcc/jjae190.0307
Published: 22 January 2025
Journal Article
P0254 Cost of telemonitoring with the App TECCU in Inflammatory Bowel Disease compared to standard care in Spain: a multicenter clinical trial of GETECCU Free
M Aguas Peris and others
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i683–i685, https://doi.org/10.1093/ecco-jcc/jjae190.0428
Published: 22 January 2025
Journal Article
P0119 Elevated Circulating Succinate in Crohn's Disease Correlates with Gut Microbiota Alterations and Inflammatory Activity Free
A Boronat-Toscano and others
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i500–i501, https://doi.org/10.1093/ecco-jcc/jjae190.0293
Published: 22 January 2025
Journal Article
P0170 The presence of creeping fat in a TNBS-induced colitis model is associated with greater acute inflammation and bacterial translocation Free
R Suau and others
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i570, https://doi.org/10.1093/ecco-jcc/jjae190.0344
Published: 22 January 2025
Journal Article
P230 Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry Free
L Madero Velázquez and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i562–i563, https://doi.org/10.1093/ecco-jcc/jjad212.0360
Published: 24 January 2024
Journal Article
P1193 NOD2 and Beyond: Unmasking Tobacco-Induced Epigenetic Changes in Crohn's Disease Free
I Vañó and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i2112–i2113, https://doi.org/10.1093/ecco-jcc/jjad212.1323
Published: 24 January 2024
Journal Article
P649 Long-term follow-up of the PROTDILAT study; LONG-PROTDILAT Prospective multicenter randomized comparative study of endoscopic treatment of strictures in Crohn's disease (CD): self-expandable metal stent (SEMS) vs endoscopic balloon dilatation (EBD) Free
P Ruiz Ramírez and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Page i1226, https://doi.org/10.1093/ecco-jcc/jjad212.0779
Published: 24 January 2024
Journal Article
P022 Development of a novel experimental model for studying creeping fat in Crohn's Disease Free
L Clua and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i272–i273, https://doi.org/10.1093/ecco-jcc/jjad212.0152
Published: 24 January 2024
Journal Article
P643 Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study Free
P Sanz Segura and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i774–i775, https://doi.org/10.1093/ecco-jcc/jjac190.0773
Published: 30 January 2023
Journal Article
P625 Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis Free
J Llaó and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i755–i756, https://doi.org/10.1093/ecco-jcc/jjac190.0755
Published: 30 January 2023
Journal Article
OP26 Impact of telemonitoring on the management of Inflammatory Bowel Disease in Spain: a multicenter TECCU clinical trial Free
M Aguas Peris and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i35–i37, https://doi.org/10.1093/ecco-jcc/jjac190.0026
Published: 30 January 2023
Journal Article
OP23 Asymptomatic inflammatory bowel disease diagnosed during the colorectal cancer population screening in Catalonia Free
E Brunet and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i31–i32, https://doi.org/10.1093/ecco-jcc/jjac190.0023
Published: 30 January 2023
Journal Article
P410 Long-term persistence and safety of biological drugs in patients with Inflammatory Bowel Disease. Differences between women and men: SEXEII study of ENEIDA Free
C Gargallo-Puyuelo and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i539–i540, https://doi.org/10.1093/ecco-jcc/jjac190.0540
Published: 30 January 2023
Journal Article
P371 The addition of intravenous, high dose, bolus of methyl-prednisolone increases the early clinical response to oral corticosteroids in moderately active ulcerative colitis. Preliminary results of a prospective, controlled, multicentre, randomised, open-label study Free
E Domènech Moral PhD and others
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Page i374, https://doi.org/10.1093/ecco-jcc/jjab232.498
Published: 21 January 2022
Journal Article
P671 Effect of genetic polymorphisms in the folate pathway on the efficacy and safety of methotrexate in Crohn’s disease Free
J Salazar and others
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Page S593, https://doi.org/10.1093/ecco-jcc/jjab076.791
Published: 27 May 2021
Journal Article
P001 Succinate, a gut microbiota-derived metabolite, modulates the inflammatory status of the creeping fat in Crohn’s disease Free
C Serena and others
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Page S123, https://doi.org/10.1093/ecco-jcc/jjab076.130
Published: 27 May 2021
Journal Article
P476 Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry Free
M Chaparro and others
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S465–S466, https://doi.org/10.1093/ecco-jcc/jjab076.599
Published: 27 May 2021
Journal Article
P319 Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU Free
M J García García and others
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S345–S346, https://doi.org/10.1093/ecco-jcc/jjab076.443
Published: 27 May 2021
Journal Article
P434 Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from Eneida Registry Free
M Chaparro and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S394–S395, https://doi.org/10.1093/ecco-jcc/jjz203.563
Published: 15 January 2020
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals